Simulations Plus Inc falls on Q3 revenue miss

Simulations Plus

13/07/2021 11:27

** Simulations Plus' shares  SLP.O  are down ~12% at $47
premarket
    ** The company, which provides simulation solutions for
pharma and biotech industries, posts Q3 revenue that misses
analysts' estimates
    ** Co says it was hit by a higher-than-normal number of
late-quarter project delays and drug development program
cancellations in its services business  urn:newsml:reuters.com:*:nBw6sZBCpa
    ** Stock is down 25.75% YTD

 (Reporting by Sahil Shaw in Bengaluru)
 ((sahil.shaw@thomsonreuters.com))